Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Elitrol** is an oral fixed-dose nutritional and mineral combination marketed by Elliott Labs for calcium and bone-health support. The sponsor-provided composition comprises calcitriol, calcium citrate malate, vitamin K2-7, methylcobalamin, zinc, manganese, and L-methylfolate. Calcitriol is the active form of vitamin D and activates the vitamin D receptor to regulate calcium and phosphate homeostasis and support bone mineralization; the calcium, vitamin K2-7, trace minerals, methylcobalamin, and L-methylfolate provide complementary nutritional support. Commercial pharmacy listings describe Elitrol Softgel Capsule as a calcium-deficiency nutritional supplement marketed by Elliott Labs, although those listings report a differing composition that includes calcium carbonate and magnesium rather than calcium citrate malate and manganese. ([1mg.com](https://www.1mg.com/drugs/elitrol-softgel-capsule-912223))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Elitrol.